La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Fuan Pharmaceutical (Group) Crescita futura

Future criteri di controllo 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Fuan Pharmaceutical (Group).

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili	18.8%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Does Fuan Pharmaceutical (Group) (SZSE:300194) Have A Healthy Balance Sheet?

Jun 07

Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit

May 02

Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price

Apr 03

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché Fuan Pharmaceutical (Group) non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

SZSE:300194 - Stime future degli analisti e dati finanziari passati (CNY Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
3/31/2024	2,766	268	331	551	N/A
12/31/2023	2,648	232	113	329	N/A
9/30/2023	2,621	320	27	235	N/A
6/30/2023	2,600	278	7	296	N/A
3/31/2023	2,560	253	-152	214	N/A
1/1/2023	2,422	205	-44	339	N/A
9/30/2022	2,411	-339	43	444	N/A
6/30/2022	2,382	-316	33	363	N/A
3/31/2022	2,357	-321	33	327	N/A
1/1/2022	2,453	-297	-156	257	N/A
9/30/2021	2,374	192	-269	144	N/A
6/30/2021	2,428	184	-390	114	N/A
3/31/2021	2,446	203	-352	122	N/A
12/31/2020	2,368	209	-182	163	N/A
9/30/2020	2,490	263	-130	184	N/A
6/30/2020	2,530	272	-105	193	N/A
3/31/2020	2,627	287	-37	233	N/A
12/31/2019	2,781	293	72	296	N/A
9/30/2019	2,729	-363	119	315	N/A
6/30/2019	2,647	-380	125	245	N/A
3/31/2019	2,633	-375	137	248	N/A
12/31/2018	2,669	-360	136	268	N/A
9/30/2018	2,661	277	94	227	N/A
6/30/2018	2,583	276	277	390	N/A
3/31/2018	2,403	283	327	442	N/A
12/31/2017	2,091	285	N/A	453	N/A
9/30/2017	1,904	303	N/A	526	N/A
6/30/2017	1,742	320	N/A	460	N/A
3/31/2017	1,535	281	N/A	447	N/A
12/31/2016	1,297	222	N/A	374	N/A
9/30/2016	1,069	171	N/A	316	N/A
6/30/2016	909	121	N/A	254	N/A
3/31/2016	799	86	N/A	199	N/A
12/31/2015	708	65	N/A	161	N/A
9/30/2015	631	57	N/A	100	N/A
6/30/2015	514	40	N/A	81	N/A
3/31/2015	459	38	N/A	20	N/A
12/31/2014	449	46	N/A	-31	N/A
9/30/2014	430	50	N/A	-21	N/A
6/30/2014	409	49	N/A	-37	N/A
3/31/2014	372	39	N/A	35	N/A
12/31/2013	358	38	N/A	90	N/A
9/30/2013	345	40	N/A	78	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Insufficient data to determine if 300194's forecast earnings growth is above the savings rate (2.9%).

Guadagni vs Mercato: Insufficient data to determine if 300194's earnings are forecast to grow faster than the CN market

Guadagni ad alta crescita: Insufficient data to determine if 300194's earnings are expected to grow significantly over the next 3 years.

Ricavi vs Mercato: Insufficient data to determine if 300194's revenue is forecast to grow faster than the CN market.

Ricavi ad alta crescita: Insufficient data to determine if 300194's revenue is forecast to grow faster than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if 300194's Return on Equity is forecast to be high in 3 years time

Fuan Pharmaceutical (Group) Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

Fuan Pharmaceutical (Group) Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

Does Fuan Pharmaceutical (Group) (SZSE:300194) Have A Healthy Balance Sheet?

Fuan Pharmaceutical (Group) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 04 June 2024

Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit

Fuan Pharmaceutical (Group) Co., Ltd. Proposes Final Cash Dividend for 2023

Fuan Pharmaceutical (Group) Co., Ltd., Annual General Meeting, May 24, 2024

First quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.07 in 1Q 2023)

Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price

Fuan Pharmaceutical (Group) Co., Ltd. to Report Q1, 2024 Results on Apr 25, 2024

Investor sentiment deteriorates as stock falls 17%

Fuan Pharmaceutical (Group) Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.04 in 3Q 2022)

Investor sentiment improves as stock rises 19%

Second quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.04 in 2Q 2022)

Fuan Pharmaceutical (Group) Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 12 May 2023

First quarter 2023 earnings released: EPS: CN¥0.07 (vs CN¥0.03 in 1Q 2022)

Now 22% undervalued

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.06 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.04 in 2Q 2021)

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.05 in 2Q 2020)

Fuan Pharmaceutical (Group) Co., Ltd. Announces Implementation of Profit Distribution Plan for A Shares for the Year 2020, Payable on 14 May 2021

First quarter 2021 earnings released: EPS CN¥0.05 (vs CN¥0.06 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.18 (vs CN¥0.25 in FY 2019)

Fuan Pharmaceutical (Group) Co., Ltd. to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: CN¥4.18

New 90-day low: CN¥4.74

Investor sentiment deteriorated over the past week

New 90-day low: CN¥5.42

New 90-day high - CN¥6.57

Fuan Pharmaceutical (Group) Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥6.27

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita